Who founded ApiJect Holdings?

ApiJect Holdings was founded by Jay Walker in 2022.

How much funding has ApiJect Holdings raised?

ApiJect Holdings has disclosed $111M raised across 1 round.

Where is ApiJect Holdings headquartered?

ApiJect Holdings is headquartered in Stamford, US.

ApiJect Holdings

Stamford, US · Founded 2022 · Delaware corporation

Find your way into ApiJect Holdings

35 people in our graph share verified history with the ApiJect Holdings team — schools, employers, funds. One of them is your warm intro.

Mike Zakunlockedknows Jay Walker · together at Cornell (overlapped)

×11knows the team · via Cornell

ApiJect develops a platform for producing prefilled injectable medicines and vaccines, aimed at making injectable drug delivery safer and more accessible. It serves manufacturers of sterile liquid products in the pharmaceutical and healthcare industry.

Advanced Manufacturing Hardware Healthtech Medical Devices

Founders & leadership

ApiJect Holdings was founded in 2022 by Jay Walker.

Jay Walker inFounder · Executive ChairmanJay Walker founded Priceline and Synapse Group and holds a B.S. in Industrial Relations from Cornell. He serves as Chairman and CEO of ApiJect Systems Corp., focusing on platforms for producing prefilled injectable medicines and vaccines.

Peter StoneNamed on SEC filing

Hanjin InNamed on SEC filing

Raphael BejaranoNamed on SEC filing

Marc KoskaNamed on SEC filing

Kevin SheridanNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$111M disclosed across 1 round · 2022

▶$111MraisedMay 2022 · 4 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Peter StoneExecutive Officer
Hanjin InDirector
Raphael BejaranoDirector
Jay WalkerDirector, Executive Officer
Marc KoskaDirector
Kevin SheridanDirector

Offering amount: $162.4M
Amount sold: $111M
Proceeds to insiders: $7.9M
First sale: Apr 2022
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Tempus33 shared keywordsTempus AI develops artificial intelligence-powered diagnostic tests that integrate genomic, clinical, and imaging data to guide personalized treatment decisions in oncology and other disease areas. The company operates a technology platform that connects healthcare institutions to aggregate and analyze multimodal patient data, serving physicians, pharmaceutical companies, and healthcare systems seeking to optimize therapy selection and drug development.

Boston Scientific28 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.

Paragon2823 shared keywordsParagon 28 manufactures the PRECISION MIS Bunion System, a minimally invasive surgical instrument set for correcting bunion deformities through metatarsal osteotomy and fixation. The system is designed for orthopedic surgeons and hospitals performing bunion correction procedures.

Companies competing with ApiJect Holdings for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does ApiJect Holdings do?: ApiJect develops a platform for producing prefilled injectable medicines and vaccines, aimed at making injectable drug delivery safer and more accessible. It serves manufacturers of sterile liquid products in the pharmaceutical and healthcare industry.
Who founded ApiJect Holdings?: ApiJect Holdings was founded by Jay Walker in 2022.
How much funding has ApiJect Holdings raised?: ApiJect Holdings has disclosed $111M raised across 1 round.
Where is ApiJect Holdings headquartered?: ApiJect Holdings is headquartered in Stamford, US.